IMCR

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.25
Percentage change 0.80	%

Peers: MRNA REGN AMGN VRTX BIIB BNTX BMY GILD INCY NVAX

| Held by: IBB SPDW SBIO GWX ONEQ CANC BBP GINN CNCR ISCF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	2.74%	Shs Outstand	50.03M	Perf Week	0.15%
Market Cap	1.55B	Forward P/E	-	EPS next Y	-1.40	Insider Trans	0.00%	Shs Float	48.66M	Perf Month	-8.10%
Income	-47.13M	PEG	-	EPS next Q	-0.24	Inst Own	87.82%	Short Float	14.77%	Perf Quarter	-7.55%
Sales	297.79M	P/S	5.21	EPS this Y	25.02%	Inst Trans	22.41%	Short Ratio	26.17	Perf Half Y	-21.85%
Book/sh	7.51	P/B	4.13	EPS next Y	-65.48%	ROA	-5.71%	Short Interest	7.19M	Perf Year	-49.87%
Cash/sh	18.01	P/C	1.72	EPS next 5Y	-	ROE	-12.85%	52W Range	29.72 - 76.98	Perf YTD	-54.60%
Dividend Est.	-	P/FCF	74.04	EPS past 5Y	-	ROI	-5.82%	52W High	-59.71%	Beta	0.73
Dividend TTM	-	Quick Ratio	3.76	Sales past 5Y	88.61%	Gross Margin	99.12%	52W Low	4.36%	ATR (14)	1.49
Dividend Ex-Date	-	Current Ratio	3.78	EPS Y/Y TTM	29.74%	Oper. Margin	-22.94%	RSI (14)	41.79	Volatility	4.99% 4.77%
Employees	497	Debt/Eq	1.27	Sales Y/Y TTM	26.48%	Profit Margin	-15.83%	Recom	1.59	Target Price	67.73
Option/Short	Yes / Yes	LT Debt/Eq	1.14	EPS Q/Q	275.51%	Payout	-	Rel Volume	0.42	Prev Close	30.77
Sales Surprise	1.66%	EPS Surprise	149.55%	Sales Q/Q	24.43%	Earnings	Nov 06 BMO	Avg Volume	274.61K	Price	31.02
SMA20	-3.06%	SMA50	-3.93%	SMA200	-27.35%	Trades		Volume	93,742	Change	0.80%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	Mizuho	Outperform → Neutral	$72 → $38
Oct-24-24	Initiated	UBS	Sell	$24
Oct-07-24	Downgrade	Guggenheim	Buy → Neutral
Apr-29-24	Initiated	Leerink Partners	Outperform	$74
Nov-20-23	Resumed	JP Morgan	Overweight	$60
Nov-02-23	Initiated	Cantor Fitzgerald	Overweight
Oct-31-23	Initiated	Robert W. Baird	Outperform	$84
Sep-13-23	Upgrade	JP Morgan	Neutral → Overweight	$9 → $22
Sep-13-23	Initiated	Needham	Buy	$75
Aug-16-23	Initiated	CapitalOne	Overweight	$84
Jul-17-23	Initiated	Canaccord Genuity	Hold	$67
Mar-31-23	Initiated	Mizuho	Buy	$70
Mar-30-23	Initiated	Guggenheim	Buy	$85
Mar-24-23	Initiated	Bryan Garnier	Buy	$16
Dec-16-22	Upgrade	Goldman	Neutral → Buy	$33 → $80
Nov-30-22	Initiated	Barclays	Overweight	$80
Sep-09-22	Initiated	Morgan Stanley	Overweight	$77
Sep-08-22	Initiated	Ladenburg Thalmann	Buy	$82
Aug-08-22	Initiated	Cowen	Outperform	$70
Aug-02-22	Initiated	BTIG Research	Buy	$85

Show Previous Ratings

Today 12:00PM	All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy (Zacks)
07:12AM	Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial (TipRanks)
Dec-11-24 07:00AM	EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma (GlobeNewswire)
Dec-03-24 01:00AM	Immunocore announces reimbursement agreement in England for KIMMTRAK? for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma (GlobeNewswire)
Nov-28-24 09:55AM	Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect? (Zacks)
08:58AM	Loading…
Nov-19-24 08:58AM	Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode (Insider Monkey)
Nov-18-24 08:25AM	Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-08-24 09:55AM	Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know (Zacks)
07:00AM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Nov-06-24 07:00AM	Immunocore reports third quarter financial results and provides a business update (GlobeNewswire)
Nov-05-24 12:00PM	Immunocore (IMCR) Upgraded to Buy: Here's Why (Zacks) +5.84%
Oct-09-24 05:31PM	Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ... (GuruFocus.com)
Sep-29-24 07:43AM	Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now (Insider Monkey)
Sep-27-24 05:17AM	Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy (Insider Monkey)
Sep-25-24 11:29AM	Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales (Insider Monkey)
05:12PM	Loading…
Sep-14-24 05:12PM	Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock (Insider Monkey)
03:00AM	Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer (GlobeNewswire)
Sep-12-24 04:05PM	Immunocore to present at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
01:30AM	Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ... (GuruFocus.com)
Sep-05-24 08:30AM	Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics (PR Newswire)
Aug-30-24 01:16AM	Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds (Insider Monkey)
Aug-29-24 07:00AM	Immunocore announces transition of Chief Financial Officer (GlobeNewswire)
Aug-08-24 07:00AM	Immunocore reports second quarter financial results and provides a business update (GlobeNewswire)
Aug-06-24 10:41AM	3 Small-Cap Stocks with Significant Growth Potential (InvestorPlace)
Aug-01-24 07:00AM	Immunocore to report second quarter 2024 financial results and host call on August 8, 2024 (GlobeNewswire)
Jun-18-24 07:00AM	Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma (GlobeNewswire)
Jun-01-24 08:00AM	Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response (GlobeNewswire)
May-31-24 04:05PM	Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 (GlobeNewswire) -12.74%
May-30-24 04:00PM	Immunocore to present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-29-24 07:00AM	Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma (GlobeNewswire)
12:00PM	Loading…
May-24-24 12:00PM	Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know. (Barrons.com)
May-08-24 01:54PM	IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:35AM	Immunocore Holdings' Shares Fall After Q1 Net Loss Widens (MT Newswires)
08:38AM	Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts (GuruFocus.com)
07:00AM	Immunocore reports first quarter financial results and provides a business update (GlobeNewswire)
Apr-29-24 07:15AM	Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target (MT Newswires)
Apr-24-24 10:00AM	Immunocore announces upcoming presentation and posters at ASCO 2024 (GlobeNewswire)
Apr-04-24 04:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Mar-13-24 11:07AM	Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio (InvestorPlace)
Mar-05-24 04:30PM	Immunocore presented two posters at CROI 2024 (GlobeNewswire)
Mar-01-24 07:00AM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Feb-29-24 10:51AM	Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 04:53PM	Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ... (GuruFocus.com)
07:34AM	Immunocore reports fourth quarter and full year 2023 financial results and provides a business update (GlobeNewswire)
Feb-22-24 07:00AM	Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial (GlobeNewswire)
Feb-21-24 07:00AM	Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 (GlobeNewswire)
Feb-01-24 09:00AM	DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay (PR Newswire)
05:16AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last? (Zacks)
Jan-30-24 11:30PM	Immunocore Prices Upsized Convertible Senior Notes Offering (GlobeNewswire) -6.19% +6.87%
Jan-29-24 04:05PM	Immunocore Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Jan-10-24 09:55AM	Should You Buy Immunocore Holdings PLC Sponsored ADR (IMCR) After Golden Cross? (Zacks)
Jan-09-24 01:51PM	Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets. (Barrons.com) +5.95%
Jan-05-24 07:00AM	Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation (GlobeNewswire)
Jan-03-24 07:00AM	Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 12:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-13-23 09:55AM	How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32% (Zacks)
Nov-30-23 04:00AM	Levicept Appoints Eliot Forster as CEO (GlobeNewswire) +6.83%
Nov-27-23 09:55AM	Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect? (Zacks)
Nov-20-23 09:55AM	Bears are Losing Control Over Immunocore Holdings PLC Sponsored ADR (IMCR), Here's Why It's a 'Buy' Now (Zacks)
Nov-14-23 09:09AM	11 Best Undervalued UK Stocks To Buy Now (Insider Monkey)
Nov-10-23 09:55AM	Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High? (Zacks)
Nov-07-23 07:00AM	Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +5.71%
Nov-01-23 04:01PM	Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023 (GlobeNewswire)
Oct-30-23 04:30PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Oct-21-23 08:45AM	Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial (GlobeNewswire)
Oct-19-23 09:55AM	Wall Street Analysts See a 60.86% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High? (Zacks)
Oct-07-23 03:33PM	12 Stock Picks From Our Healthcare Roundtable Pros. Weight Loss Isnt the Only Big Deal in Medicine. (Barrons.com)
Oct-06-23 07:01AM	Immunocore announces upcoming presentation and posters at ESMO 2023 (GlobeNewswire)
Sep-22-23 06:40PM	Cardlytics, Immunocore, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-14-23 02:02PM	10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts (Insider Monkey)
Sep-11-23 05:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Sep-01-23 04:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Aug-13-23 07:15AM	Immunocore Holdings plc (NASDAQ:IMCR) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 10:22PM	Q2 2023 Immunocore Holdings PLC Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-08-23 08:48AM	Why Earnings Season Could Be Great for Immunocore (IMCR) (Zacks)
Aug-03-23 08:00AM	Immunocore to report second quarter 2023 financial results and host call on August 10, 2023 (GlobeNewswire)
Jul-18-23 06:05AM	Immunocore Holdings (NASDAQ:IMCR) shareholders have earned a 41% return over the last year (Simply Wall St.)
Jun-07-23 06:59AM	With 45% stake, Immunocore Holdings plc (NASDAQ:IMCR) seems to have captured institutional investors' interest (Simply Wall St.)
Jun-03-23 07:00AM	Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO (GlobeNewswire)
Jun-01-23 04:30PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
May-17-23 01:18AM	Why companies dont want to list in the UK any more (Financial Times)
May-11-23 06:00AM	Immunocore Holdings First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-10-23 07:00AM	Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-03-23 04:30PM	Immunocore to present at the Bank of America Securities 2023 Health Care Conference (GlobeNewswire)
Apr-24-23 01:00AM	Capitalism without the capital (Financial Times)
Apr-19-23 12:00AM	Britains capitalism without capital: the pension funds that shun risk (Financial Times)
Apr-18-23 07:00AM	Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival (GlobeNewswire)
07:00AM	Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023 (PR Newswire)
Apr-17-23 08:32AM	Immunocore Holdings plc's (NASDAQ:IMCR) Share Price Not Quite Adding Up (Simply Wall St.)
Apr-11-23 07:00AM	Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-05-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
Mar-30-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:00AM	Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-28-23 03:57PM	Top 10 Growth Stocks in Biotech (Insider Monkey)
Mar-24-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know (Zacks)
Mar-16-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Gains But Lags Market: What You Should Know (Zacks)
09:00AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-14-23 04:30PM	Immunocore to present four posters at AACR Annual Meeting 2023 (GlobeNewswire)
Mar-03-23 10:55AM	Immunocore Holdings plc (NASDAQ:IMCR) Q4 2022 Earnings Call Transcript (Insider Monkey)

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX - Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
St Leger Tina Amber	CHIEF HR OFFICER	Apr 01 '24	Option Exercise	29.87	4,375	130,681	4,375	Apr 03 04:15 PM
St Leger Tina Amber	CHIEF HR OFFICER	Apr 01 '24	Sale	64.06	4,375	280,262	0	Apr 03 04:15 PM
Berman David M	HEAD OF R&D	Feb 28 '24	Option Exercise	17.46	36,509	637,447	36,509	Mar 01 04:15 PM
Berman David M	HEAD OF R&D	Feb 28 '24	Sale	68.59	36,509	2,504,158	0	Mar 01 04:15 PM
Berman David M	HEAD OF R&D	Feb 27 '24	Option Exercise	17.46	54,938	959,217	54,938	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 26 '24	Option Exercise	17.46	28,553	498,535	28,553	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 27 '24	Sale	70.86	54,938	3,893,030	0	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 26 '24	Sale	70.65	28,553	2,017,288	0	Feb 28 04:15 PM
St Leger Tina Amber	Chief HR Officer	Jan 03 '24	Option Exercise	29.87	4,375	130,681	4,375	Jan 05 04:17 PM
St Leger Tina Amber	Chief HR Officer	Jan 03 '24	Sale	69.89	4,375	305,781	0	Jan 05 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Immunocore Holdings plc ADR

Upgrade your FINVIZ experience